0℃
COMMENT|ONLINE FIRST
The overlooked pandemic of antimicrobial resistance
Ramanan Laxminarayan
Lancet Published:January 19, 2022
DOI:https://doi.org/10.1016/S0140-6736(22)00087-3
As COVID-19 rages on, the pandemic of antimicrobial resistance (AMR) continues in the shadows. The toll taken by AMR on patients and their families is largely invisible but is reflected in prolonged bacterial infections that extend hospital stays and cause needless deaths.1 Moreover...
阅读全文
0℃
ARTICLES|ONLINE FIRST
Identification of phenotypes in paediatric patients with acute respiratory distress syndrome: a latent class analysis
Mary K Dahmer, Guangyu Yang, Min Zhang, et al
Lancet Respir Med Published: December 06, 2021
DOI:https://doi.org/10.1016/S2213-2600(21)00382-9
Summary
Background
Previous latent class analysis of adults with acute respiratory distress syndrome (ARDS) identified two phenotypes, distinguished by the degree of inflam...
阅读全文
0℃
ORIGINAL ARTICLE
Early Remdesivir to Prevent Progression to Severe Covid-19 in Outpatients
Robert L. Gottlieb, Carlos E. Vaca, Roger Paredes, et al
N Engl J Med 2022; 386:305-315DOI: 10.1056/NEJMoa2116846
Abstract
BACKGROUND
Remdesivir improves clinical outcomes in patients hospitalized with moderate-to-severe coronavirus disease 2019 (Covid-19). Whether the use of remdesivir in symptomatic, nonhospitalized patients with Covid-19 who are at high risk for...
阅读全文
0℃
ICU Management & Practice, Volume 21 - Issue 4, 2021
Should Families Be Allowed To Visit Dying COVID-19 Patients in the ICU?
COVID-19 has drastically changed how end-of-life care is practiced in the intensive care unit. Safety concerns for society limits family visitation but is contrary to patient and family-oriented care. This article provides an ethical analysis of the pros and cons of having family members present at the death of a COVID-19 positive ICU...
阅读全文
0℃
ARTICLES|ONLINE FIRST
Single-dose of adrecizumab versus placebo in acute cardiogenic shock (ACCOST-HH): an investigator-initiated, randomised, double-blinded, placebo-controlled, multicentre trial
Mahir Karakas, Ibrahim Akin, Christoph Burdelski, et al
Lancet Respir Med Published: December 08, 2021
DOI:https://doi.org/10.1016/S2213-2600(21)00439-2
Summary
Background
Cardiogenic shock has a high mortality on optimal therapy. Adrenomedullin is released ...
阅读全文
0℃
Insights from the PRoVENT-COVID Study
Mortality in patients with COVID-19 is much higher in patients who need invasive ventilation for acute respiratory distress syndrome (ARDS). COVID-19 patients with ARDS are a heterogeneous group with diverse evolutions that could be due to different phenotypes and response to care, including invasive ventilation strategies.
The Practice of VENTilation in COVID-19 (PRoVENT-COVID) study was conducted to investigate change...
阅读全文
0℃
ARTICLES| VOLUME 9, ISSUE 12, P1427-1438, DECEMBER 01, 2021
Effect of anti-interleukin drugs in patients with COVID-19 and signs of cytokine release syndrome (COV-AID): a factorial, randomised, controlled trial
Jozefien Declercq, Karel F A Van Damme, Elisabeth De Leeuw, et al
Lancet Respir Med 2021; 9: 1427-1438
Summary
Background
Infections with SARS-CoV-2 continue to cause significant morbidity and mortality. Interleukin (IL)-1 and IL-6 ...
阅读全文
0℃
COMMENT|ONLINE FIRST
COVID-19 will continue but the end of the pandemic is near
Christopher J L Murray
Lancet Published:January 19, 2022
DOI:https://doi.org/10.1016/S0140-6736(22)00100-3
The world is experiencing a huge wave of infection with the omicron variant of SARS-CoV-2. Estimates based on Institute for Health Metrics and Evaluation (IHME) models1 suggest that on around Jan 17, 2022 there were 125 million omicron infections a day in the world, which i...
阅读全文
0℃
Enriching the Term “Palliative”
Palliative care is an important component of the medical course of many patients. This is particularly applicable for patients with cancer, neurodegenerative diseases, and heart, respiratory or liver failure. However, the term palliative is used uniformly, whatever the stages of disease evolution or the specific therapeutic avenues that might still be possible. It might be more practical to use more nuanced and discriminating te...
阅读全文
0℃
ARTICLES| VOLUME 9, ISSUE 12, P1419-1426, DECEMBER 01, 2021
Colchicine in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
RECOVERY Collaborative Group
Lancet Respir Med 2021; 9: 1419-1426
Summary
Background
Colchicine has been proposed as a treatment for COVID-19 based on its anti-inflammatory actions. We aimed to evaluate the efficacy and safety of colchicine in patients admitte...
阅读全文